These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
90 related articles for article (PubMed ID: 21937396)
1. New clinical scoring system for prognosis of early recurrence of colorectal liver metastases after surgical treatment. Alan S; Vaclav L; Martin P; Vladislav T; Ondrej T; Tomas S; Stanislav K; Lubos H Hepatogastroenterology; 2011; 58(109):1286-90. PubMed ID: 21937396 [TBL] [Abstract][Full Text] [Related]
2. Clinical relevance of the expression of mRNA of MMP-7, MMP-9, TIMP-1, TIMP-2 and CEA tissue samples from colorectal liver metastases. Sutnar A; Pesta M; Liska V; Treska V; Skalicky T; Kormunda S; Topolcan O; Cerny R; Holubec L Tumour Biol; 2007; 28(5):247-52. PubMed ID: 17992052 [TBL] [Abstract][Full Text] [Related]
3. Clinicopathological assessment and quantitative estimation of the matrix metalloproteinases MMP-2 and MMP-7 and the inhibitors TIMP-1 and TIMP-2 in colorectal carcinoma tissue samples. Pesta M; Topolcan O; Holubec L; Rupert K; Cerna M; Holubec LS; Treska V; Finek J; Cerny R Anticancer Res; 2007; 27(4A):1863-7. PubMed ID: 17649785 [TBL] [Abstract][Full Text] [Related]
4. Circulating gelatinases and tissue inhibitor of metalloproteinase-1 in colorectal cancer metastatic liver disease. Waas ET; Wobbes T; Ruers T; Lomme RM; Hendriks T Eur J Surg Oncol; 2006 Sep; 32(7):756-63. PubMed ID: 16650961 [TBL] [Abstract][Full Text] [Related]
5. Quantitative estimation of matrix metalloproteinases 2 and 7 (MMP-2, MMP-7) and tissue inhibitors of matrix metalloproteinases 1 and 2 (TIMP-1, TIMP-2) in colorectal carcinoma tissue samples. Pesta M; Holubec L; Topolcan O; Cerna M; Rupert K; Holubec LS; Treska V; Kormunda S; Elgrova L; Finek J; Cerny R Anticancer Res; 2005; 25(5):3387-91. PubMed ID: 16101153 [TBL] [Abstract][Full Text] [Related]
6. [Expression and clinical significance of MMP-2, MMP-9,TIMP-1, and TIMP-2 in breast carcinoma]. Fan SQ; Wei QY; Li MR; Zhang LQ; Liang QC Ai Zheng; 2003 Sep; 22(9):968-73. PubMed ID: 12969531 [TBL] [Abstract][Full Text] [Related]
7. [Expression of matrix metalloproteinases and tissue inhibitors of matrix metalloproteinases in the hepatocellular carcinomas]. Wei QY; Wu YQ; Fan SQ Hunan Yi Ke Da Xue Xue Bao; 2003 Jun; 28(3):212-6. PubMed ID: 14653069 [TBL] [Abstract][Full Text] [Related]
8. Limited value of preoperative serum analyses of matrix metalloproteinases (MMP-2, MMP-9) and tissue inhibitors of matrix metalloproteinases (TIMP-1, TIMP-2) in colorectal cancer. Oberg A; Höyhtyä M; Tavelin B; Stenling R; Lindmark G Anticancer Res; 2000; 20(2B):1085-91. PubMed ID: 10810401 [TBL] [Abstract][Full Text] [Related]
9. [Expression of matrix metalloproteinases-9,2,7,and tissue inhibitor of metalloproteinases-1,2,3 mRNA in ovarian tumors and their clinical significance]. Hu XX; Li L; Li DR; Zhang W; Cheng XQ; Zhang JQ; Tang BJ Ai Zheng; 2004 Oct; 23(10):1194-8. PubMed ID: 15473934 [TBL] [Abstract][Full Text] [Related]
10. Tissue inhibitor of metalloproteinase 1 is an independent predictor of prognosis in patients with nonsmall cell lung carcinoma who undergo resection with curative intent. Gouyer V; Conti M; Devos P; Zerimech F; Copin MC; Créme E; Wurtz A; Porte H; Huet G Cancer; 2005 Apr; 103(8):1676-84. PubMed ID: 15754326 [TBL] [Abstract][Full Text] [Related]
11. Dynamics of serum levels of tumour markers and prognosis of recurrence and survival after liver surgery for colorectal liver metastases. Liska V; Holubec L; Treska V; Skalicky T; Sutnar A; Kormunda S; Pesta M; Finek J; Rousarova M; Topolcan O Anticancer Res; 2007; 27(4C):2861-4. PubMed ID: 17695461 [TBL] [Abstract][Full Text] [Related]
12. A comparative study of protein expression in primary colorectal cancer and synchronous hepatic metastases: the significance of matrix metalloproteinase-1 expression as a predictor of liver metastasis. Kim YW; Ko YT; Kim NK; Chung HC; Min BS; Lee KY; Park JP; Kim H Scand J Gastroenterol; 2010; 45(2):217-25. PubMed ID: 20095886 [TBL] [Abstract][Full Text] [Related]
13. Elevated tissue inhibitor of metalloproteinase 1 RNA in colorectal cancer stroma correlates with lymph node and distant metastases. Zeng ZS; Cohen AM; Zhang ZF; Stetler-Stevenson W; Guillem JG Clin Cancer Res; 1995 Aug; 1(8):899-906. PubMed ID: 9816060 [TBL] [Abstract][Full Text] [Related]
14. Significance of matrix metalloproteinases and tissue inhibitors of metalloproteinase expression in the recurrence of superficial transitional cell carcinoma of the bladder. Hara I; Miyake H; Hara S; Arakawa S; Kamidono S J Urol; 2001 May; 165(5):1769-72. PubMed ID: 11342973 [TBL] [Abstract][Full Text] [Related]
15. A novel prognostic index in colorectal cancer defined by serum carcinoembryonic antigen and plasma tissue inhibitor of metalloproteinases-1. Nielsen HJ; Christensen IJ; Brünner N Scand J Gastroenterol; 2010; 45(2):200-7. PubMed ID: 20095885 [TBL] [Abstract][Full Text] [Related]
16. Preoperative tumor markers as prognostic factors of colorectal liver metastases. Treska V; Topolcan O; Stanislav K; Liska V; Holubec L Hepatogastroenterology; 2009; 56(90):317-20. PubMed ID: 19579590 [TBL] [Abstract][Full Text] [Related]
17. Low preoperative serum carcinoembryonic antigen concentration is a marker of good prognosis in patients undergoing cryotherapy for low volume hepatic metastases from colorectal cancer. Seifert JK; Morris DL Int J Surg Investig; 2000; 2(4):327-34. PubMed ID: 12678536 [TBL] [Abstract][Full Text] [Related]
18. Invasion front-specific overexpression of tissue inhibitor of metalloproteinase-1 in liver metastases from colorectal cancer. Kahlert C; Bandapalli OR; Schirmacher P; Weitz J; Brand K Anticancer Res; 2008; 28(3A):1459-65. PubMed ID: 18630499 [TBL] [Abstract][Full Text] [Related]
19. Clinical significance of serum CEA protein and CEA mRNA after resection of colorectal liver metastases. Kijima M; Togo S; Ichikawa Y; Miura M; Yamagishi S; Matsuo K; Tanaka K; Masui H; Ishikawa T; Ike H; Shimada H Anticancer Res; 2005; 25(2B):1327-32. PubMed ID: 15865086 [TBL] [Abstract][Full Text] [Related]
20. A comparison of tumour M2-PK with carcinoembryonic antigen and CA19-9 in patients undergoing liver resection for colorectal metastases. Kumar Y; Pinedo IR; Tapuria N; Zabron A; Davidson BR Eur J Gastroenterol Hepatol; 2008 Oct; 20(10):1006-11. PubMed ID: 18787469 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]